4.1 Article

BAYESIAN HIERARCHICAL MODELING FOR DETECTING SAFETY SIGNALS IN CLINICAL TRIALS

Journal

JOURNAL OF BIOPHARMACEUTICAL STATISTICS
Volume 21, Issue 5, Pages 1006-1029

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10543406.2010.520181

Keywords

Bayesian hierarchical models; Clinical trials; Drug safety; Multiplicity; Signal detection

Ask authors/readers for more resources

Detection of safety signals from clinical trial adverse event data is critical in drug development, but carries a challenging statistical multiplicity problem. Bayesian hierarchical mixture modeling is appealing for its ability to borrow strength across subgroups in the data, as well as moderate extreme findings most likely due merely to chance. We implement such a model for subject incidence (Berry and Berry, 2004) using a binomial likelihood, and extend it to subject-year adjusted incidence rate estimation under a Poisson likelihood. We use simulation to choose a signal detection threshold, and illustrate some effective graphics for displaying the flagged signals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available